
    
      This is a prospective, phase 2 study. The main objectives are to assess acute and late side
      effects of single fraction SBRT for selected patients with vertebral metastases and to study
      the local control of disease in treated sites.

      The schedule will be 1 fraction of 18 Gy delivered in one day with Volumetric Modulated Arc
      Therapy (VMAT) and Flattening filter-free (FFF) beams.
    
  